BBOTVSLABT• 3 Months (Normalized)
BBOT vs LABT (BridgeBio Oncology Therapeutics Inc. vs Lakewood-Amedex Biotherapeutics Inc.)
Showing Closing Date Range from Jul 4 to Oct 2, 2026.
Normalized cumulative comparison anchored at 0.00% baseline to illustrate pure alpha, return divergence, and market momentum.
BBOT Performance $3.89
-53.75%
BridgeBio Oncology Therapeutics Inc.
Normalized Baseline0.00%
LABT Performance $0.93
-65.96%
Lakewood-Amedex Biotherapeutics Inc.
Normalized Baseline0.00%
Alpha Spread Margin BBOT LEADS
+12.21 pts
BBOT outperforming by 12.21 percentage points
BBOTLABT
Spread Trajectory3 Months (Normalized)
Cumulative Performance Trajectory
Interactive divergence comparison normalized at 0.00% on start date.
BBOT LABT
Comparative Historical Ledger
Daily closing prices, normalized percentages, and relative spread divergence.
Historical Quotes & Breakdown(63 dates)
| Date | BBOT Price | BBOT Gain (%) | LABT Price | LABT Gain (%) | Spread |
|---|---|---|---|---|---|
| Oct 02, 2026 | $3.89 | -53.75% | $0.93 | -65.96% | +12.21% |
| Sep 30, 2026 | $4.10 | -51.25% | $- | - | |
| Sep 29, 2026 | $3.92 | -53.39% | $0.99 | -63.87% | +10.48% |
| Sep 28, 2026 | $3.81 | -54.70% | $1.15 | -58.03% | +3.33% |
| Sep 25, 2026 | $3.95 | -53.03% | $1.67 | -39.05% | -13.98% |
| Sep 24, 2026 | $3.99 | -52.56% | $1.83 | -33.21% | -19.35% |
| Sep 23, 2026 | $4.16 | -50.54% | $1.78 | -35.04% | -15.50% |
| Sep 22, 2026 | $4.66 | -44.59% | $1.99 | -27.37% | -17.22% |
| Sep 21, 2026 | $4.66 | -44.59% | $2.05 | -25.18% | -19.41% |
| Sep 18, 2026 | $4.77 | -43.28% | $1.99 | -27.37% | -15.91% |
| Sep 17, 2026 | $4.89 | -41.85% | $1.86 | -32.12% | -9.73% |
| Sep 16, 2026 | $4.76 | -43.40% | $2.09 | -23.72% | -19.68% |
| Sep 15, 2026 | $4.88 | -41.97% | $2.17 | -20.80% | -21.17% |
| Sep 14, 2026 | $5.05 | -39.95% | $2.12 | -22.63% | -17.32% |
| Sep 11, 2026 | $4.95 | -41.14% | $2.22 | -18.98% | -22.16% |
Page 1 of 5